Via Cyte Inc San Diego, CA - 92121

Via Cyte Inc is categorized under Noncommercial Research Organizations in San Diego, CA and active since 1999.

Via Cyte Inc was established in 1999, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 5417110 by the NAICS.

If you are seeking more information, feel free to contact Paul Laikind, Chief Executive Officer at the company’s headquarters by writing to 3550 General Atomics Court, San Diego, California CA 92121 or by phoning (858) 455-3708. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Via Cyte Inc
Contact Person: Paul Laikind, Chief Executive Officer
Address: 3550 General Atomics Court, San Diego, California 92121
Phone Number: (858) 455-3708
Website Address: viacyte.com
Annual Revenue (USD): Unknown
Founded: 1999
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 5417110
Share This Business:

Via Cyte Inc was started in 1999 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Paul Laikind, Chief Executive Officer for inquiries that concern Via Cyte Inc by calling the company number (858) 455-3708, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Via Cyte Inc can be found at the coordinates 32.89416,-117.2372 as well as the street address 3550 General Atomics Court in San Diego, California 92121.

For its online presence, you may visit Via Cyte Inc’s website at viacyte.com and engage with its social media outlets through on Twitter and on Facebook.